Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
3 (75.0%)Phase 2
1 (25.0%)Polypill Versus Metformin in New Onset Type 2 Diabetes
Phase 2
Not yet recruiting
- Conditions
- Type 2 Diabetes
- Interventions
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- George Medicines PTY Limited
- Target Recruit Count
- 334
- Registration Number
- NCT05833958
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- Drug: Telmisartan 20 mg/amlodipine 2.5 mg
- First Posted Date
- 2020-08-19
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- George Medicines PTY Limited
- Target Recruit Count
- 1385
- Registration Number
- NCT04518293
- Locations
- 🇺🇸
Elite Clinical Studies, Phoenix, Arizona, United States
🇺🇸Headlands Research, Scottsdale, Arizona, United States
🇺🇸Quality of Life Medical & Research Associates, Tucson, Arizona, United States
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2020-08-19
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- George Medicines PTY Limited
- Target Recruit Count
- 755
- Registration Number
- NCT04518306
- Locations
- 🇺🇸
Elite Clinical Studies, Phoenix, Arizona, United States
🇺🇸Headlands Research, Scottsdale, Arizona, United States
🇺🇸Quality of Life Medical & Research Centers, LLC, Tucson, Arizona, United States
News
No news found